These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4189895)

  • 1. [Side effect after administration of a heparin-heparinoid mixture in man].
    Hörder MH; Hey D; Brunswig D
    Arzneimittelforschung; 1969 Nov; 19(11):1876-8. PubMed ID: 4189895
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of heparin-heparinoid-mixtures].
    Hörder MH; Stier WD; Brunswig D
    Arzneimittelforschung; 1969 Nov; 19(11):1873-6. PubMed ID: 4190000
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cutaneous delayed hypersensitivity reactions to heparins and heparinoids].
    Figarella I; Barbaud A; Lecompte T; De Maistre E; Reichert-Penetrat S; Schmutz JL
    Ann Dermatol Venereol; 2001 Jan; 128(1):25-30. PubMed ID: 11226896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diffuse alopecia due to a synthetic heparinoid].
    Beurey J; Weber M; Gurecki H; Vadot J; Fournier A
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(3):389-92. PubMed ID: 4177676
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids.
    Boehncke WH; Weber L; Gall H
    Contact Dermatitis; 1996 Aug; 35(2):73-5. PubMed ID: 8917822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
    Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
    Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potentiation of acenocoumarol after application of an semi-synthetic heparinoid].
    Potel G; Maulaz B; Pabceuf C; Toyze MD; Baron D
    Therapie; 1989; 44(1):67-8. PubMed ID: 2472016
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prophylaxis of postoperative thromboembolic disease: heparinate or heparinoid? 1000 cases].
    Malavaud A; Bichain N; Nicolas D; Sethian M
    Anesth Analg (Paris); 1970; 27(2):225-35. PubMed ID: 4192784
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of Tavan (SP-54) on the coagulation mechanism and fibrinolysis in patients receiving anticoagulant therapy].
    Kleynhans P; Retief FP; Bosman AR
    S Afr Med J; 1969 Dec; 43(49):1504-7. PubMed ID: 4188315
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
    Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of activity, in the field of orthopedic traumatology, between a heparin- and heparinoid-based cream and one based only on heparinoid].
    Peruzzini V; Luzzati A
    Boll Chim Farm; 1984 Apr; 123(4):36S-41S. PubMed ID: 6206878
    [No Abstract]   [Full Text] [Related]  

  • 13. [Controlled clinical trial of a topical heparin- and heparinoid- based cream in the treatment of vascular diseases].
    Ghiringhelli L
    Boll Chim Farm; 1984 Apr; 123(4):42S-46S. PubMed ID: 6206879
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral lichen planus: clinical and histological evaluation in an open trial using a low molecular weight heparinoid (sulodexide).
    Femiano F; Scully C
    Int J Dermatol; 2006 Aug; 45(8):986-9. PubMed ID: 16911394
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R; Glässl A; Landthaler M; Stolz W
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contrary influencing of the eosinophil count by heparin and heparinoids].
    Schuster J
    Med Exp Int J Exp Med; 1969; 19(1):17-21. PubMed ID: 4188899
    [No Abstract]   [Full Text] [Related]  

  • 17. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
    Jappe U; Juschka U; Kuner N; Hausen BM; Krohn K
    Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bibliographies on diseases of medical progress. Adverse reactions to heparin and heparinoids.
    Moser RH
    Clin Pharmacol Ther; 1968; 9(2):255-8. PubMed ID: 4170817
    [No Abstract]   [Full Text] [Related]  

  • 19. [The potentiation of the heparin effect by heparinoids. 4. On the action mechanism of heparinoids].
    Pulver R
    Arzneimittelforschung; 1965 Nov; 15(11):1320-3. PubMed ID: 4166203
    [No Abstract]   [Full Text] [Related]  

  • 20. Alopecia and other toxic effects of heparin and synthetic heparinoids.
    HIRSCHBOECK JS; MADISON FW; PISCIOTTA AV
    Am J Med Sci; 1954 Mar; 227(3):279-82. PubMed ID: 13138595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.